Biomarkers of inhalation - what’s new and what is useful in smoking cessation and reduction trials?


Source: Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Biomarkers of inhalation - what’s new and what is useful in smoking cessation and reduction trials?. Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?
Source: Eur Respir J 2009; 33: 468-480
Year: 2009



Is the e-mail useful in a smoking cessation cllinic??
Source: Annual Congress 2013 –Smoking cessation
Year: 2013

Pharmacotherapy for smoking cessation - what is available and how effective is it?
Source: Annual Congress 2003 - PG20 - Smoking reduction and smoking cessation - an update and suggestions for future studies
Year: 2003

Smoking cessation with bupropion - is it successful enough?
Source: Eur Respir J 2005; 26: Suppl. 49, 388s
Year: 2005

Are we addressing relevant determinants of smoking cessation?
Source: Eur Respir J, 50 (5) 1701615; 10.1183/13993003.01615-2017
Year: 2017



Is motivational Q-mat test useful to predict smoking cessation?
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012

The stage-of-change model in smoking cessation in respiratory patients: does it need to be revisited?
Source: Eur Respir Mon; 2008: 42: 51–56
Year: 2008

The challenge with cigarette smoke - the way to predict lung disease development in the future.
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


Recommendations to improve smoking cessation outcomes from people with lung conditions who smoke
Source: ERJ Open Res 2016: 00009-2016
Year: 2016



Smoking cessation: a critical investigative tool in COPD
Source: Eur Respir J 2006; 27: 860-861
Year: 2006


Follow-up loss in smoking cessation consultation: can we predict and prevent it?
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019


Are e-cigarettes effective and safe for smoking cessation?
Source: International Congress 2014 – PG14 Smoking cessation in patients with pulmonary disorders
Year: 2014


Current clinical management of smoke inhalation injuries: a reality check
Source: Eur Respir J, 52 (6) 1802163; 10.1183/13993003.02163-2018
Year: 2018



Harmful effects of smoking: are they adequate reasoning for smokers to quit it?
Source: Annual Congress 2009 - Smoking cessation
Year: 2009


The practical application of clinical guidelines for smoking cessation in adolescents: The final assessment point and the effectiveness of interventions
Source: International Congress 2015 – Smoking cessation
Year: 2015

Efficacy of instant messages applications in smoking cessation in patients with COPD.
Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine
Year: 2021


smoking cessation program: where do our patients come from?
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018

Do e-cigarettes induce smoking cessation?
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015